Analyst Upgrades – NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA) Stock Gets Upgraded By Chardan Capital from Neutral ➝ Buy to

ME Staff
-
0

Analyst Ratings For NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)

Today, NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA) stock received an upgrade by Chardan Capital from Neutral ➝ Buy.

Some recent analyst ratings include

  • 5/15/2018-Chardan Capital Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
  • 5/1/2018-Cann Reiterated Rating of Hold.
  • 3/15/2018-Wedbush Reiterated Rating of Outperform.
  • 3/14/2018-Leerink Swann Reiterated Rating of Outperform.
  • 3/8/2018-JMP Securities initiated coverage with a Mkt Outperform ➝ Outperform rating.
  • 12/18/2017-Oppenheimer Reiterated Rating of Hold.

Recent Insider Trading Activity For NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)
NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA) has insider ownership of 3.20% and institutional ownership of 54.70%.

  • On 3/20/2018 Jean Francois Formela, Director, sold 39,245 with an average share price of $23.87 per share and the total transaction amounting to $936,778.15.
  • On 1/29/2018 Caribou Biosciences, Inc., Major Shareholder, sold 550,645 with an average share price of $26.78 per share and the total transaction amounting to $14,746,273.10.
  • On 12/12/2017 Institutes For Biomed Novartis, Major Shareholder, sold 1,523,000 with an average share price of $18.30 per share and the total transaction amounting to $27,870,900.00.
  • On 12/8/2017 Nessan Bermingham, CEO, sold 336,783 with an average share price of $20.78 per share and the total transaction amounting to $6,998,350.74.
  • On 12/6/2017 Nessan Bermingham, CEO, sold 111,500 with an average share price of $20.34 per share and the total transaction amounting to $2,267,910.00.
  • On 7/11/2017 Venture Fund Ix L.P. Atlas, Major Shareholder, sold 150,000 with an average share price of $16.24 per share and the total transaction amounting to $2,436,000.00.
  • On 3/10/2017 Jean Francois Formela, Director, sold 21,132 with an average share price of $13.91 per share and the total transaction amounting to $293,946.12.

Recent Trading Activity for NASDAQ:NTLA – Intellia Therapeutics (NASDAQ:NTLA)
Shares of NASDAQ:NTLA – Intellia Therapeutics closed the previous trading session at 24.68 up +0.09 0.37% with 25.799999237060547 shares trading hands.